Each year, the National Health Law Program (NHeLP) spends the month of April celebrating the lifesaving program that is Medicaid. Medicaid provides quality health care to more than 80 million people in the nation. Below is a curated selection or resources and cases we believe highlight our advocacy over the past year.
- July 28, 2022
Essential Health Benefits: Best Practices in Benchmark Selection
Wayne Turner and Héctor Hernández-DelgadoThe Affordable Care Act (ACA) established a comprehensive set of ten Essential Health Benefits (EHB) that most health plans…
- May 16, 2022
Medicaid Coverage of Advanced Practice Prescribing for Reproductive & Sexual Health Medications
Liz McCaman Taylor and Cathren CohenAdvanced practice providers (APPs) are licensed health care practitioners, other than physicians, who may practice independently and bill directly…
- May 3, 2022
Scope of Practice and Medicaid: State Flexibility to Cover Advanced Practice Care
Liz McCaman Taylor and Cathren CohenAdvanced practice providers (APPs) are licensed health care practitioners, other than physicians, who may practice independently and bill directly…
- May 2, 2022
NHeLP Comments on CMS Request for Information on Access to Coverage and Care in Medicaid & CHIP
Charly Gilfoil, Cat Duffy, Abigail Coursolle, Mara Youdelman, Wayne Turner, Jennifer Lav, Elizabeth Edwards, and David MachledtThe Centers for Medicare & Medicaid Services (CMS) issued a Request for Information (RFI) to develop and implement a…
- April 14, 2022
NHeLP comments on Oregon’s application for renewal of the Oregon Health Plan § 1115(a) Demonstration Waiver for 2022-2027
Sarah Somers and Wayne TurnerIn public comments, NHeLP expresses support for Oregon's decision to abandon its waiver of EPSDT. However, NHeLP strongly opposes…
- April 12, 2022
NHeLP Comments on the Proposed Update to the CDC’s Opioid Prescribing Guidelines
Héctor Hernández-Delgado and Alexis Robles-FradetIn these comments to the Centers for Disease Control and Prevention (CDC), NHeLPs conveys its support for the CDC's…
- April 8, 2022
More Transparency Needed to Ensure Medicaid Beneficiaries Have Access to Necessary Off-Label Prescription Drugs
Abigail CoursolleUnder federal law, state Medicaid programs are required to cover (with a few exceptions) outpatient prescription drugs for “medically…
- February 11, 2022
NHeLP letter to HHS Sec. Becerra – Re: Advancing Health Equity Through Essential Health Benefits
Wayne Turner, Héctor Hernández-Delgado, and Fabiola CarriónThe Affordable Care Act (ACA) established a comprehensive set of ten Essential Health Benefits (EHB) that most health plans…
- February 4, 2022
Coverage of Over-the-Counter Drugs in Medicaid (Revised February 2022)
Abigail Coursolle and Liz McCaman TaylorDrug coverage is an important facet of the Medicaid program. Although it is an optional benefit, all states cover…
- December 9, 2021
Contraceptive Equity Primers
Liz McCaman TaylorState Contraceptive Equity laws can play a critical role in filling the remaining gaps from the Affordable Care Act,…
- December 7, 2021
Model Contraceptive Equity Act: Legislative Language and Issue Brief
Liz McCaman TaylorUPDATED - December 2021. Contraceptive Equity is a policy framework under which contraceptive care is easily accessible and covered…
- December 6, 2021
Q&A: State Contraceptive Equity Laws
Liz McCaman TaylorThe Affordable Care Act (ACA) requires most health insurance plans to provide coverage for a broad range of women’s…
- December 3, 2020
NHeLP Comments on HHS Regulations Rule (aka SUNSET Rule)
Wayne Turner and Dania DouglasIn the Regulations Rule, HHS seeks to retroactively impose a mandatory expiration date on an estimated 18,000 duly promulgated…
- September 17, 2020
NHeLP comments on Approved Drug Products with Therapeutic Equivalence Evaluations (the “Orange Book”)
Liz McCaman TaylorThe Orange Book is an important and informative drug resource for a range of stakeholders. In a request for…
- July 20, 2020
NHeLP comments on Medicaid Prescrption Drug Rebate Program and Value- based Purchasing Proposed Rulemaking
Wayne Turner, Liz McCaman Taylor, Madeline Morcelle, and Cathren CohenIn a proposed rule, CMS seeks to expand value-based purchasing arrangements for prescription drugs in commercial plans and the…
- April 8, 2019
National Health Law Program Comments on HHS Safe Harbor Rule for Outpatient Prescription Drugs
Wayne Turner and Hayley PenanThe U.S. Department of Health and Human Services (HHS) proposed new regulations that would remove safe harbor protections for…
- December 18, 2018
Amicus Brief in Support of Maryland’s Anti-Price Gouging Law for Prescription Drugs
Wayne Turner, Abigail Coursolle, and Sarah GrusinThe National Health Law Program filed an amicus brief with the United States Supreme Court asking it to review…
- December 14, 2018
Comments to the FDA Urging Approval of Over the Counter Naloxone
Corey DavisThe National Health Law Program strongly urges the Food and Drug Administration (FDA) to initiate the process of moving…
- December 1, 2016
Fact Sheet: Utilization Controls for Medicaid Prescription Drugs
Abbi CoursolleState Medicaid programs that elect to provide outpatient prescription drug coverage must cover all FDA-approved drugs that are offered…
- November 30, 2016
Fact Sheet: Medicaid Outpatient Prescription Drugs
Michelle LilienfeldPrescription drug coverage is an important facet of the Medicaid program. Although an optional benefit, all states cover outpatient…